The Switzerland market closed on a firm note on Thursday, in line with other markets in Europe, as easing concerns about inflation and rate hikes and possibility of a U.S.-Iran peace deal aided sentiment.
The benchmark SMI, which stayed positive throughout the session, settled at 14,352.98, gaining 238.98 points or 1.69%.
Roche moved up nearly 4% as the drugmaker’s KRAS drug tops its rivals in lung cancer trial. “The superior survival demonstrated in this global head-to-head comparison of KRAS G12C inhibitors confirms the potential of divarasib to improve clinical outcomes for people with KRAS G12C non-small cell lung cancer,” said Levi Garraway, Roche’s chief medical officer.
Subscribe to continue reading the article.
This article is available exclusively to RTT Biotech Investor and Intelligent Investor subscribers. Subscribe with a RTTNews subscription.
Start Free Trial
FREE 7-Day Trial – No Payment Required
Market Analysis
Swiss Market Ends On Strong Note
2026-07-02 18:31:40
